These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 12091886)

  • 1. Ebola vaccine gets corporate backer.
    Dove A
    Nat Med; 2002 Jul; 8(7):645-6. PubMed ID: 12091886
    [No Abstract]   [Full Text] [Related]  

  • 2. [Hope for a vaccine against ebola virus].
    Holzgrabe U
    Pharm Unserer Zeit; 2001; 30(3):185-6. PubMed ID: 11400662
    [No Abstract]   [Full Text] [Related]  

  • 3. Battling Ebola: the virus and the fear.
    Fauci A; Kresge KJ
    IAVI Rep; 2014; 18(4):11-3. PubMed ID: 25622440
    [No Abstract]   [Full Text] [Related]  

  • 4. [An effective vaccine against Ebola hemorrhagic fever].
    Pospísil L
    Vnitr Lek; 2004 Jan; 50(1):76. PubMed ID: 15049337
    [No Abstract]   [Full Text] [Related]  

  • 5. Towards a vaccine against Ebola virus.
    Geisbert TW; Jahrling PB
    Expert Rev Vaccines; 2003 Dec; 2(6):777-89. PubMed ID: 14711361
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ebola virus: from discovery to vaccine.
    Feldmann H; Jones S; Klenk HD; Schnittler HJ
    Nat Rev Immunol; 2003 Aug; 3(8):677-85. PubMed ID: 12974482
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Experimental vaccine protects monkeys against Ebola virus.
    Gottlieb S
    Bull World Health Organ; 2001; 79(1):79. PubMed ID: 11217674
    [No Abstract]   [Full Text] [Related]  

  • 8. An uncertain defense. How do you test that a human Ebola vaccine works? You don't.
    Gibbs WW
    Sci Am; 2004 Oct; 291(4):20, 24. PubMed ID: 15487661
    [No Abstract]   [Full Text] [Related]  

  • 9. A single shot against Ebola and Marburg virus.
    Baize S
    Nat Med; 2005 Jul; 11(7):720-1. PubMed ID: 16015361
    [No Abstract]   [Full Text] [Related]  

  • 10. Development of a cAdVax-based bivalent ebola virus vaccine that induces immune responses against both the Sudan and Zaire species of Ebola virus.
    Wang D; Raja NU; Trubey CM; Juompan LY; Luo M; Woraratanadharm J; Deitz SB; Yu H; Swain BM; Moore KM; Pratt WD; Hart MK; Dong JY
    J Virol; 2006 Mar; 80(6):2738-46. PubMed ID: 16501083
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Potential vaccine candidates against Ebola and the first vaccine against chikungunya virus infection].
    Nau JY
    Rev Med Suisse; 2014 Aug; 10(439):1570-1. PubMed ID: 25272676
    [No Abstract]   [Full Text] [Related]  

  • 12. Virology. New vaccine and treatment excite Ebola researchers.
    Enserink M
    Science; 2003 Nov; 302(5648):1141-2. PubMed ID: 14615510
    [No Abstract]   [Full Text] [Related]  

  • 13. Ebola vaccine is safe and immunogenic, results show.
    Gulland A
    BMJ; 2015 Jan; 350():h524. PubMed ID: 25633684
    [No Abstract]   [Full Text] [Related]  

  • 14. Immunology of protection from Ebola virus infection.
    Krause PR; Bryant PR; Clark T; Dempsey W; Henchal E; Michael NL; Regules JA; Gruber MF
    Sci Transl Med; 2015 May; 7(286):286ps11. PubMed ID: 25947159
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Effects of repeated administration of Ebola virus preparations on dynamics of immunologic parameters].
    Chepurnov AA; Dadaeva AA; Sizikova LP
    Biull Eksp Biol Med; 1999 Jan; 127(1):81-5. PubMed ID: 10190013
    [No Abstract]   [Full Text] [Related]  

  • 16. Do therapeutic antibodies hold the key to an effective treatment for Ebola hemorrhagic fever?
    Takada A
    Immunotherapy; 2013 May; 5(5):441-3. PubMed ID: 23638738
    [No Abstract]   [Full Text] [Related]  

  • 17. Ethical dilemma for Ebola drug trials.
    Hayden EC
    Nature; 2014 Nov; 515(7526):177-8. PubMed ID: 25391940
    [No Abstract]   [Full Text] [Related]  

  • 18. Persistent immune responses after Ebola virus infection.
    Sobarzo A; Ochayon DE; Lutwama JJ; Balinandi S; Guttman O; Marks RS; Kuehne AI; Dye JM; Yavelsky V; Lewis EC; Lobel L
    N Engl J Med; 2013 Aug; 369(5):492-3. PubMed ID: 23902512
    [No Abstract]   [Full Text] [Related]  

  • 19. Ebola virus-like particle-based vaccine protects nonhuman primates against lethal Ebola virus challenge.
    Warfield KL; Swenson DL; Olinger GG; Kalina WV; Aman MJ; Bavari S
    J Infect Dis; 2007 Nov; 196 Suppl 2():S430-7. PubMed ID: 17940980
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influences of glycosylation on antigenicity, immunogenicity, and protective efficacy of ebola virus GP DNA vaccines.
    Dowling W; Thompson E; Badger C; Mellquist JL; Garrison AR; Smith JM; Paragas J; Hogan RJ; Schmaljohn C
    J Virol; 2007 Feb; 81(4):1821-37. PubMed ID: 17151111
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.